about
Dissecting the genomic complexity underlying medulloblastomaDivergence of imprinted genes during mammalian evolution.Imprinted genes show unique patterns of sequence conservation.Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.Coverage bias and sensitivity of variant calling for four whole-genome sequencing technologiesBRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia.A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing.Repetitive elements in imprinted genes.Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age.Hypermutation of the inactive X chromosome is a frequent event in cancer.Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling.Recurrent CDKN1B (p27) mutations in hairy cell leukemia.Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.Identifying CpG islands by different computational techniques.Integrative genomic and transcriptomic analysis of leiomyosarcoma.NRG1 Fusions in KRAS Wild-type Pancreatic Cancer.Tandem repeats in the CpG islands of imprinted genesWhole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancerDefective homologous recombination DNA repair as therapeutic target in advanced chordomaTargetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumorsGenomic footprints of activated telomere maintenance mechanisms in cancerComprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemiaMetastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare diseaseIdentification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domainsThe landscape of chromothripsis across adult cancer types
P50
Q24621907-6EC471C1-B32E-4B27-B6A4-F45DACB82EB5Q30981938-9D43915E-C590-4187-A2E1-FB2FC7CCA961Q33751959-E83CD608-1390-4F33-87E9-11D0887A0410Q34354839-0E56DB84-A9CB-400C-A9CA-01538A9D80DFQ34776833-AD2B5C96-FBC2-4861-A44E-537D65B01069Q35140116-1490998A-617C-47A6-8E5D-8AF8157528B3Q36379244-DC92CF77-CBDB-4AB7-BAF8-992A832A5752Q36436539-075F8EBA-23C4-4D31-91CE-825652106A71Q36544705-38F7CDE0-DD79-445B-92EE-56050A76EB6FQ37503144-ECFD8DD9-AA08-4EE7-B96D-98ED8216124CQ39538403-F7B7D533-9F86-45C8-B5DD-7AC7B54C403DQ40305624-821DE5E7-9DE0-4AB6-876E-A2313F07D910Q40845395-4380BF40-8360-4A31-9C6D-565FBC6E1A58Q45017329-DADB86BA-EBB5-471C-948F-EF4E363274E8Q46132049-59A5671D-1A37-4153-BAC0-E9B46D3FC997Q47739736-2B07B6CA-0532-4C2C-A700-B9E4BCB4589FQ54978186-61DE9DB1-ECE3-4187-AEF7-168BDAE19F1DQ57814751-B18CADD4-3F16-4577-9214-99FBC975E617Q59137310-F0569811-1E5B-43AE-9B8E-7C511E677730Q63071454-F103AE60-6532-4256-8C80-8FDB5701E073Q89526901-B2FEE655-BAD6-459E-8671-75A58FEED1EFQ89555508-1544BB0E-442C-452E-9E4B-BD564C3659EDQ90010381-E9CD63DF-4D5E-4018-8614-9882A6596FCEQ90198084-AF18FC54-D28D-472C-A1B5-B3894F90709FQ90317829-41385635-8ABA-4917-BC12-9F5BEDB69486Q94570127-408B8904-29C4-4495-8047-AE3BAAF527D8
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Barbara Hutter
@ast
Barbara Hutter
@en
Barbara Hutter
@es
Barbara Hutter
@nl
Barbara Hutter
@sl
type
label
Barbara Hutter
@ast
Barbara Hutter
@en
Barbara Hutter
@es
Barbara Hutter
@nl
Barbara Hutter
@sl
prefLabel
Barbara Hutter
@ast
Barbara Hutter
@en
Barbara Hutter
@es
Barbara Hutter
@nl
Barbara Hutter
@sl
P214
P106
P21
P214
P31
P496
0000-0002-9034-0329
P734
P735
P7859
lccn-no2013079327